Alterity Therapeutics Limited logo
Alterity Therapeutics Limited ATHE
$ 3.29 -4.64%

Annual report 2022
added 08-31-2022

report update icon

Alterity Therapeutics Limited Net Income 2011-2026 | ATHE

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Alterity Therapeutics Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-12.8 M -15.3 M -13.5 M -12.3 M -8.27 M -7.54 M -7.73 M -5.89 M -13.3 M -7.79 M -5.24 M -6.43 M

All numbers in AUD currency

Indicator range from annual reports

Maximum Minimum Average
-5.24 M -15.3 M -9.68 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
Assembly Biosciences Assembly Biosciences
ASMB
-6.12 M $ 28.46 3.45 % $ 319 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-384 M $ 221.88 -0.87 % $ 5 B danmarkDanmark
MorphoSys AG MorphoSys AG
MOR
-514 M - 2.43 % $ 254 M germanyGermany
Axsome Therapeutics Axsome Therapeutics
AXSM
-183 M $ 156.92 -1.23 % $ 7.81 B usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
149 M - -32.59 % $ 7.61 M usaUSA
Pharming Group N.V. Pharming Group N.V.
PHAR
33 M $ 15.36 -0.71 % $ 7.59 B niderlandNiderland
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-221 M $ 1.37 -4.2 % $ 350 M britainBritain
Kamada Ltd. Kamada Ltd.
KMDA
-2.23 M $ 8.5 -1.39 % $ 260 M israelIsrael
I-Mab I-Mab
IMAB
-1.47 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
603 M - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
67.3 M - 2.54 % $ 160 B franceFrance
Benitec Biopharma Benitec Biopharma
BNTC
-8.8 M $ 10.98 -4.52 % $ 452 M usaUSA
Inventiva S.A. Inventiva S.A.
IVA
-49.6 M $ 5.78 -4.3 % $ 138 M franceFrance
Biophytis SA Biophytis SA
BPTS
-31.2 M - -13.47 % $ 169 M franceFrance
Compugen Ltd. Compugen Ltd.
CGEN
35.3 M $ 2.09 -0.95 % $ 195 M israelIsrael
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
-23.4 M $ 1.21 -3.97 % $ 71.5 M britainBritain
ARCA biopharma ARCA biopharma
ABIO
-83.7 M - 1052.0 % $ 415 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.46 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-8.09 M - -1.52 % $ 24.7 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.37 M - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-18.4 M - - $ 26.5 M usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
-14.6 M $ 2.28 -0.44 % $ 1.03 M israelIsrael
Acorda Therapeutics Acorda Therapeutics
ACOR
-253 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
-9.57 M - 4.01 % $ 150 M canadaCanada
Foghorn Therapeutics Foghorn Therapeutics
FHTX
-74.3 M $ 5.0 2.25 % $ 315 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
72.9 M - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-131 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-26.2 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
-48.1 M - -9.65 % $ 45.9 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
-146 M $ 3.4 -3.68 % $ 1.02 B canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
349 M $ 54.13 -1.64 % $ 10.4 B usaUSA
Curis Curis
CRIS
-43.4 M $ 0.77 1.89 % $ 4.86 M usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-19.8 M - -74.18 % $ 955 K usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
-14.8 M - -10.17 % $ 12.2 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
168 M $ 1.52 -5.59 % $ 178 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-155 M - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-412 M - - $ 867 M germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
172 M $ 7.7 -5.87 % $ 1.29 B britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
-252 M - - $ 3.67 B usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
-125 M $ 3.34 -4.02 % $ 116 M franceFrance
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-72.8 M $ 4.24 -2.97 % $ 704 M canadaCanada
Akouos Akouos
AKUS
-86.7 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-34 M - -0.23 % $ 916 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-14.7 M - 1.93 % $ 17.4 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
-45.9 M $ 1.8 -1.1 % $ 120 M usaUSA
Allakos Allakos
ALLK
-186 M - - $ 28.6 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
-67.7 M $ 2.94 -3.29 % $ 3.43 M usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-24.8 M $ 0.16 -5.45 % $ 3.15 M irlandaIrlanda
Brickell Biotech Brickell Biotech
BBI
-5.69 M - -5.38 % $ 6.06 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-48.7 M - 3.16 % $ 1.9 M usaUSA